| Product Name |
CAS Registry Number |
Molecular Formula |
| 2-(2'-Hydroxydodecanoyl)Amino-1-Phenyl-1,3-Propanediol | 41613-09-6 | C21H35NO4 |
| (3R,5Z)-3-Hydroxy-5-dodecenoic acid | 88456-81-9 | C12H22O3 |
| 2-hydroxydodecyl-bis(2-hydroxyethyl)-methyl-ammonium, 4-methylbenzenesulfonate | 94249-11-3 | C24H45NO6S |
| N-(2-Hydroxydodecyl)-N-(2-hydroxyethyl)-beta-alanine | 70521-70-9 | C17H35NO4 |
| N-(2-Hydroxydodecyl)-N-(2-Hydroxyethyl)-beta-Alanine Monosodium Salt | 70521-74-3 | |
| 6-(11-Hydroxydodecyl)-2-(Hydroxymethyl)Piperidin-3-Ol | 14058-38-9 | C18H37NO3 |
| Hydroxydodecyl Methacrylate | 76736-66-8 | C16H30O3 |
| 12-Hydroxydodecyl methacrylate | 86282-42-0 | C16H30O3 |
| 6-[(11R)-11-Hydroxydodecyl]-3-Methoxy-2-Methyl-1H-Pyridin-4-One | 70001-21-7 (83542-31-8) | C19H33NO3 |
| 3-[(2-Hydroxydodecyl)Methylamino]Propane-1,2-Diol | 60659-36-1 | C16H35NO3 |
| 2-Hydroxydodecyl 2-Methylprop-2-Enoate | 13438-18-1 | C16H30O3 |
| 3-[(2-Hydroxydodecyl)Oxy]Propane-1,2-Diol | 2984-32-9 | C15H32O4 |
| 5-Hydroxydopa | 16032-83-0 | C9H11NO5 |
| 5-Hydroxydopamine | 1927-04-4 | C8H12ClNO3 |
| 2-Hydroxydopamine | 4228-71-1 | C8H11NO3 |
| 6-Hydroxydopamine hydrobromide | 636-00-0 | C8H11NO3.HBr |
| 5-Hydroxydopamine Hydrochloride | 5720-26-3 | C8H12ClNO3 |
| 6-Hydroxydopaquinone | 135791-48-9 | C9H9NO5 |
| 6-Hydroxydopa Quinone | 64192-68-3 | C9H9NO5 |
| (E)-2-Hydroxy Doxepin | 131523-90-5 | C19H21NO2 |
| (E)-3-Hydroxy Doxepin | 131523-97-2 | C19H21NO2 |
| (Z)-8-Hydroxy Doxepin | 250331-51-2 | C19H21NO2 |
| 5beta-Hydroxy Drospirenone | 197721-70-3 | C24H32O4 |
| 5’-Hydroxy Drospirenone | 863329-71-9 | C24H32O3 |
| 5beta-Hydroxy Drospirenone Ring-opened Alcohol | 1357252-81-3 | C24H36O4 |
| 4-Hydroxy Duloxetine beta-D-Glucuronide | 741693-83-4 | C24H27NO8S |
| (3alpha,16alpha)-6-Hydroxy-Eburnamenin-14(15H)-One | 101242-46-0 | C19H22N2O2 |
| Hydroxyecdysone | 5289-74-7 | C27H44O7 |
| 20-Hydroxyecdysone 3-acetate | 22961-68-8 | C29H46O8 |
| 8-Hydroxy Efavirenz | 205754-33-2 | C14H9ClF3NO3 |
| rac 7-Hydroxy Efavirenz | 205754-50-3 | C14H9ClF3NO3 |
| ent-8-Hydroxy Efavirenz | 342621-26-5 | C14H9ClF3NO3 |
| 2-Hydroxy-Eicosanoic Acid | 16742-48-6 | C20H40O3 |
| 11-Hydroxy-10-Eicosanone | 4443-65-6 | C20H40O2 |
| (6E,8Z,11Z,14Z,17Z)-5-Hydroxy-6,8,11,14,17-Eicosapentaenoic acid | 83952-40-3 | C20H30O3 |
| 15(S)-Hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoic acid | 86282-92-0 | C20H30O3 |
| (5S,6E,8Z,11Z,14Z,17Z)-5-Hydroxy-6,8,11,14,17-Eicosapentaenoic Acid | 92008-51-0 | |
| 15-Hydroxy-5,8,11,13,17-Eicosapentaenoic Acid | 97850-14-1 | C20H30O3 |
| 18-Hydroxy-5,8,11,14-Eicosatetraenoic Acid | 21914-83-0 | C20H32O3 |
| 12(S)-Hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoic acid | 54397-83-0 | C20H32O3 |
| (15S,5Z,8Z,11Z,13E)-15-Hydroxyeicosatetraenoic acid | 54845-95-3 | C20H32O3 |
| 12-Hydroxy-5,8,10,14-Eicosatetraenoic Acid | 59985-28-3 | C20H32O3 |
| (5Z,8Z,10E,14Z)-12-Hydroxy-5,8,10,14-Eicosatetraenoicacid | 71030-37-0 | C20H32O3 |
| 5-Hydroxy-6,8,11,14-Eicosatetraenoic Acid | 72255-35-7 | C20H32O3 |
| (6E,8Z,11Z,14Z)-5-Hydroxy-6,8,11,14-Eicosatetraenoic Acid | 73307-52-5 | C20H32O3 |
| (5Z,9E,11Z,14Z)-8-Hydroxy-5,9,11,14-Eicosatetraenoic Acid | 79495-84-4 | C20H32O3 |
| (5Z,7E,11Z,14Z)-9-hydroxy-5,7,11,14-Eicosatetraenoic Acid | 79495-85-5 | C20H32O3 |
| 20-Hydroxyeicosa-5Z,8Z,11Z,14Z-tetraenoic acid | 79551-86-3 | C20H32O3 |
| (5Z,9E,11Z,14Z)-(8S)-8-Hydroxyeicosa-5,9,11,14-tetraenoic acid | 98462-03-4 | C20H32O3 |
| 5-Hydroxyeicosatetraenoic Acid Lactone | 81517-87-5 | C20H30O2 |